R

Ruth R. Wexler

Bristol-Myers Squibb (Germany)

ORCID: 0000-0001-5514-5053

292 papers and 12.6k citations.

PubIndex Score97Top 3%How it's scored

292Publications

12.6kTotal Citations

First senior author: 1994

Top publicationsby citations

MEK inhibitors: The chemistry and biological activity of U0126, its analogs, and cyclization products

John V. Duncia, Richard E. Olson, Christopher A. Teleha et al.|Bioorganic & Medicinal Chemistry Letters|1998

Cited by 406

Discovery of Two Novel Antiplatelet Clinical Candidates (BMS-986120 and BMS-986141) That Antagonize Protease-Activated Receptor 4

E. Scott Priestley, Anne Marinier, Jacques Banville et al.|Journal of Medicinal Chemistry|2022

Cited by 27

Discovery of Potent and Selective Quinoxaline-Based Protease-Activated Receptor 4 (PAR4) Antagonists for the Prevention of Arterial Thrombosis

X. Zhang, E. Scott Priestley, Wen Jiang et al.|Journal of Medicinal Chemistry|2024

Cited by 12

Discovery of BMS-986308: A Renal Outer Medullary Potassium Channel Inhibitor for the Treatment of Heart Failure

Jeremy M. Richter, E. Scott Priestley, Prashantha Gunaga et al.|Journal of Medicinal Chemistry|2024

Cited by 7

Design and Synthesis of Novel Meta-Linked Phenylglycine Macrocyclic FVIIa Inhibitors

Jeremy M. Richter, E. Scott Priestley, Daniel L. Cheney et al.|ACS Medicinal Chemistry Letters|2016

Cited by 6

Indexing the rest of 292 publications…